TipRanks
Go Ultimate55% OFF

IRLAB Therapeutics AB Class A (6IRA) Balance Sheet

IRLAB Therapeutics AB Class A Balance Sheet

IRLAB Therapeutics AB Class A's total assets for Q2 2026 were $182.37M, an increase of 35.06% from the previous quarter. DE:6IRA total liabilities were $85.24M for the fiscal quarter, a 10.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 138.21M$ 136.21M$ 177.12M$ 323.56M$ 472.45M
$ 107.49M$ 103.58M$ 61.36M$ 32.72M$ 72.97M
$ 30.72M$ 32.63M$ 115.76M$ 290.83M$ 399.48M

Currency in SEK

IRLAB Therapeutics AB Class A Debt to Assets

0200M400M600M0 %30 %60 %90 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets